A significant breakthrough in cancer study is arising with the use of mini-antibodies to reactivate mutated p53. This crucial malignant inhibitor protein is frequently lost in various forms of tumors, resulting https://bookmarkbooth.com/story21969617/vhh-fragments-reactivate-p53-a-potential-approach-for-malignant-treatment